Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 725 of 1631 entries
View as:

A Study in Which Non-metastatic Castration-resistant Prostate Cancer (nmCRPC) Patients for Whom a Decision to Treat With Darolutamide Has Been Made Before Enrollment Are Observed and Certain Outcomes Are Described

Phase: N/A Priority: Normal
NCT ID: NCT04122976 Org: User:
Start: 01/30/20 End: 10/07/26 Due: 10/07/27

An Observational Study to Learn More About the Safety of Darolutamide in Men With Prostate Cancer in Korea

Phase: N/A Priority: Normal
NCT ID: NCT06334120 Org: User:
Start: 09/25/24 End: 06/30/26 Due: 06/30/27

A Study to Test the Safety and Efficacy of the Drug Larotrectinib for the Treatment of Tumors With NTRK-fusion in Children

Phase: N/A Priority: Normal
NCT ID: NCT02637687 Org: User:
Start: 12/16/15 End: 09/30/26 Due: 09/30/27

Prospective, Non-interventional, Post-authorization Safety Study That Includes All Patients Diagnosed as Unresectable Differentiated Thyroid Carcinoma and Treated With Sorafenib

Phase: N/A Priority: Normal
NCT ID: NCT02185560 Org: User:
Start: 06/27/14 End: 11/30/25 Due: 11/30/26

A Study to Gather Information About the Progress and Outcomes of Pregnancy in Women Using Various Vitamin Support Plans Before and During Pregnancy

Phase: N/A Priority: Normal
NCT ID: NCT05062044 Org: User:
Start: 12/01/21 End: 06/30/25 Due: 06/30/26

Curing Atopic Dermatits in Children With a Commerical Medical Device and Maintaining Healthy Skin by Using a New Cosmetic Product

Phase: N/A Priority: Normal
NCT ID: NCT02615561 Org: User:
Start: 12/15/15 End: 09/07/16 Due: 09/07/17

Study to Compare How the Body Absorbs, Distributes and Excretes the Drug Selitrectinib (BAY2731954) Given as Two Different Tablet Formulations or as Liquid Formulations Including the Effect of Food on the Absorption, Distribution or Excretion of the Different Formulations in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT04771390 Org: User:
Start: 02/16/21 End: 07/06/21 Due: 07/06/22

Study to Learn More About Outcomes Reported by Patients Suffering From Type 2 Diabetes Using a Digital Data Collection Tool

Phase: N/A Priority: Normal
NCT ID: NCT04383041 Org: User:
Start: 07/02/20 End: 01/27/21 Due: 01/27/22

Community-Acquired Pneumonia (CAP) Surveillance

Phase: N/A Priority: Normal
NCT ID: NCT01416506 Org: User:
Start: 09/30/10 End: 01/31/13 Due: 01/31/14

Open Label Regorafenib Study to Evaluate Cardiovascular Safety Parameters, Tolerability, and Anti-tumor Activity

Phase: N/A Priority: Normal
NCT ID: NCT01339104 Org: User:
Start: 04/30/11 End: 08/31/13 Due: 08/31/14

Effect of Regorafenib on Digoxin and Rosuvastatin in Patients With Advanced Solid Malignant Tumors.

Phase: N/A Priority: Normal
NCT ID: NCT02106845 Org: User:
Start: 04/22/14 End: 06/12/18 Due: 06/12/19

A Non-interventional Study to Observe the Computed Tomographic Angiography Image Quality With Different Contrast Media Injection Protocols Under Different Computed Tomography Machines Parameters Setting

Phase: N/A Priority: Normal
NCT ID: NCT02840903 Org: User:
Start: 07/26/16 End: 10/11/17 Due: 10/11/18

Efficacy of Gynodian® Depot in Women With Impaired Well-being

Phase: N/A Priority: Normal
NCT ID: NCT00463450 Org: User:
Start: 05/31/02 End: 04/30/04 Due: 04/30/05

Phase III Double-blind Comparative Study of BAY77-1931 (Lanthanum Carbonate) With Calcium Carbonate

Phase: N/A Priority: Normal
NCT ID: NCT01514851 Org: User:
Start: 01/31/06 End: 05/31/06 Due: 05/31/07

A Phase III Study of Sorafenib in Patients With Advanced Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00105443 Org: User:
Start: 03/31/05 End: 11/30/08 Due: 11/30/09

HCC Patient Preferences in Japan

Phase: N/A Priority: Normal
NCT ID: NCT02616692 Org: User:
Start: 05/09/16 End: 10/07/16 Due: 10/07/17

The Effect of Food (High Fat and Low Fat Breakfast) on the Pharmacokinetics of Regorafenib

Phase: N/A Priority: Normal
NCT ID: NCT01002378 Org: User:
Start: 10/31/09 End: 02/28/10 Due: 02/28/11

Evaluation of Sunscreen During Exercise Under Conditions of Profuse Sweating

Phase: N/A Priority: Normal
NCT ID: NCT02842268 Org: User:
Start: 06/17/16 End: 06/22/16 Due: 06/22/17

A First-in-human Study to Learn How Safe BAY 3713372 is and How it Works in Participants With MTAP-deleted Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06914128 Org: User:
Start: 03/21/25 End: 06/17/29 Due: 06/17/30

Darolutamide + Androgen Deprivation Therapy (ADT) in Chinese Men With High Risk, Nonmetastatic Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05171387 Org: User:
Start: 11/30/21 End: 02/24/25 Due: 02/24/26

A Study to Learn About How Safe Darolutamide is and How Well it Works in Combination With Androgen Deprivation Therapy and Docetaxel in Routine Medical Care for Japanese Men With Low Volume Metastatic Hormone-Sensitive Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06661122 Org: User:
Start: 11/18/24 End: 08/31/31 Due: 08/31/32

A Study to Learn About the Safety of BAY3283142 in People With Mild to Moderate High Blood Pressure

Phase: N/A Priority: Normal
NCT ID: NCT06428825 Org: User:
Start: 08/07/24 End: 11/05/25 Due: 11/05/26

An Observational Study to Learn More About How Safe Finerenone is and How Well it Works in Indian People With Chronic Kidney Disease and Type 2 Diabetes in Routine Medical Practice

Phase: N/A Priority: Normal
NCT ID: NCT06763146 Org: User:
Start: 08/01/25 End: 01/31/26 Due: 01/31/27

2-cohort Study of Adult Patients With Severe Hemophilia A in Greece

Phase: N/A Priority: Normal
NCT ID: NCT02319070 Org: User:
Start: 01/13/15 End: 02/28/18 Due: 02/28/19

Evaluating the Efficacy Vardenafil 10 mg vs Tadalafil 10 mg in in Subjects With Erectile Dysfunction (ED)

Phase: N/A Priority: Normal
NCT ID: NCT00663130 Org: User:
Start: 04/30/04 End: 07/31/04 Due: 07/31/05